No, it wasn't on "no news". Here's the news for you since you've clearly missed it, I believe. For the record, me stating you've missed it is not an attack since you stated "no news" and also claim to be a finder of facts for what I believe you mean penny stocks not pennies as in the currency.
3/4/2014
BIOHEART ANNOUNCES POSITIVE 6 MONTH DATA FROM ANGEL PHASE I TRIAL
1/29/2014
BIOHEART ANNOUNCES FIRST ADIPOSE DERIVED STEM CELL IMPLANTATION IN AZERBAIJAN
1/22/2014
BIOHEART ANNOUNCES EXCLUSIVE LICENSE IN VETERINARY MEDICINE FOR PATENTS FOR CANCER RELATED IMMUNOTHERAPY PRODUCTS
1/13/2014
BIOHEART, INC. TO PRESENT AT AMERICAN ACADEMY OF COSMETIC SURGERY
12/31/2013
BIOHEART, INC. TO PRESENT AT VAIL SYMPOSIUM’S WINTER PROGRAM ON CELL THERAPY
12/17/2013
BIOHEART ANNOUNCES CLINICAL STUDY FOR DRY MACULAR DEGENERATION
12/3/2013
BIOHEART, INC. ENTERS INTO INVESTMENT BANKING AGREEMENT WITH CASSEL SALPETER & CO.
12/2/2013
BIOHEART ANNOUNCES AGREEMENT WITH StemMD TO PROVIDE BIOHEART THERAPIES TO ITS NETWORK
11/26/2013
BIOHEART ANNOUNCES NEW CLINICAL SITE IN MEXICO
11/18/2013
BIOHEART'S PRESIDENT/CEO MIKE TOMAS NAMED CHAIR OF THE eMERGE INNOVATE ADVISORY BOARD OF eMERGE AMERICAS
11/4/2013
BIOHEART ANNOUNCES AGREEMENT WITH GLOBAL STEM CELL GROUP TO PROVIDE BIOHEART THERAPIES AND TRAINING
10/25/2013
BIOHEART ANNOUNCES AGREEMENT WITH ANOSIS TO DISTRIBUTE PRODUCTS IN THE MIDDLE EAST
10/16/2013
BIOHEART ANNOUNCES CONTRACT WITH AFRICAN-MIDDLE EAST MEDICAL (AFRIMID) TO BEGIN DISTRIBUTING STEM CELL PRODUCTS IN UGANDA
9/30/2013
BIOHEART ADDS TWO SERVICE PROVIDERS TO ITS TEAM OF RESOURCES
9/26/2013
BIOHEART ANNOUNCES POSITIVE PRELIMINARY DATA FROM PHASE I ANGEL TRIAL
9/24/2013
BIOHEART ANNOUNCES AGREEMENT WITH INVITRX TO LICENSE ADIPOSE DERIVED STEM CELLS
9/23/2013
BIOHEART BOOSTS TEAM WITH REGULATORY, FINANCE AND ADMINISTRATIVE EXPERTISE
8/28/2013
BANKER SHELDON T. ANDERSON ELECTED TO THE BOARD OF DIRECTORS OF BIOHEART, INC.
8/14/2013
BIOHEART'S PRESIDENT / CEO MIKE TOMAS APPOINTED TO WORKFORCE FLORIDA BOARD OF DIRECTORS BY GOVERNOR RICK SCOTT
8/9/2013
BIOHEART RECEIVES VALIDATED FDA REGISTRATION FOR TISSUE BANK ESTABLISHMENT
7/2/2013
BIOHEART ANNOUNCES PHASE III MIRROR TRIAL FOR MYOCELL INITIATED
